Prestige Consumer Healthcare Inc.

Listed Company

PBHCIK 0001295947NYSELarge AcceleratedPharmaceutical PreparationsFY ends Mar 31

Period

FY 2026

Revenue

$1.09B

Net Income

$190.30M

Total Assets

$3.49B

Equity

$1.89B

Shares Out

47.37M

Op. Cash Flow

$257.63M

Business

Prestige Consumer Healthcare Inc. develops, manufactures, markets, sells and distributes well-recognized, brand-name over-the-counter health and personal care products. Its main products include analgesics, eye and ear care, gastrointestinal remedies, dermatological treatments, women’s health and oral care items, as well as related personal care products. The company operates through two reportable segments: North American OTC Healthcare and International OTC Healthcare. Prestige sells its products through mass merchandisers, drug, food, dollar, convenience, club and e-commerce channels across the United States, Canada, Australia and other international markets.

Summary from filing dated 2025-05-09

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	Mar 31, 2026 2026-03-31	Mar 31, 2025 2025-03-31	Mar 31, 2024 2024-03-31
Revenues	—	—	—
Total revenues	1,089	1,138	1,125
Cost of Sales	—	—	—
Cost of sales excluding depreciation	483	494	493
Cost of sales depreciation	10	9	8
Cost of sales	493	503	501
Gross profit	596	634	624
Operating Expenses	—	—	—
Advertising and marketing	149	156	153
General and administrative	116	108	106
Depreciation and amortization	21	21	23
Goodwill and tradename impairment	0	12	0
Total operating expenses	286	298	282
Operating income	309	337	342
Other expense (income)	—	—	—
Interest expense, net	−42	−48	−67
Other expense (income), net	−10	−5	756,000
Total other expense, net	−52	−53	−66
Income before income taxes	257	284	276
Provision for income taxes	67	70	67
Net income	190	215	209
Earnings per share:	—	—	—
Basic (in USD per share)	3.93	4.32	4.21
Diluted (in USD per share)	3.91	4.29	4.17
Weighted average shares outstanding:	—	—	—
Basic (in shares)	48	50	50
Diluted (in shares)	49	50	50
Comprehensive income, net of tax:	—	—	—
Currency translation adjustments	9	−3	−3
Unrecognized net (loss) gain on pension plans	−96,000	−81,000	9,000
Total other comprehensive income (loss)	9	−3	−3
Comprehensive income	200	211	206

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	Mar 31, 2026 2026-03-31	Mar 31, 2025 2025-03-31
Assets	—	—
Current assets	—	—
Cash and cash equivalents	64	98
Accounts receivable, net of allowance of $18,187 and $16,314, respectively	192	194
Inventories	159	148
Prepaid expenses and other current assets	17	8
Total current assets	431	448
Property, plant and equipment, net	122	75
Operating lease right-of-use assets	28	28
Finance lease right-of-use assets, net	22	25
Goodwill	581	527
Intangible assets, net	2,300	2,295
Other long-term assets	11	3
Total Assets	3,494	3,402
Liabilities and Stockholders’ Equity	—	—
Current liabilities	—	—
Accounts payable	23	19
Accrued interest payable	16	16
Operating lease liabilities, current portion	7	6
Finance lease liabilities, current portion	3	2
Other accrued liabilities	73	63
Total current liabilities	121	107
Long-term debt, net	994	992
Deferred income tax liabilities	447	420
Long-term operating lease liabilities, net of current portion	21	23
Long-term finance lease liabilities, net of current portion	18	21
Other long-term liabilities	6	5
Total Liabilities	1,607	1,567
Commitments and Contingencies – Note 17	—	—
Stockholders’ Equity	—	—
Preferred stock – $0.01 par value, Authorized – 5,000 shares, Issued and outstanding – None	0	0
Issued – 56,010 shares at March 31, 2025 and 55,501 shares at March 31, 2024	562,000	560,000
Additional paid-in capital	609	593
Treasury stock, at cost – 8,892 shares at March 31, 2026 and 6,501 shares at March 31, 2025	439	277
Accumulated other comprehensive loss, net of tax	−28	−38
Retained earnings	1,746	1,556
Total Stockholders’ Equity	1,888	1,835
Total Liabilities and Stockholders’ Equity	3,494	3,402

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	Mar 31, 2026 2026-03-31	Mar 31, 2025 2025-03-31	Mar 31, 2024 2024-03-31
Operating Activities	—	—	—
Net income	190	215	209
Adjustments to reconcile net income to net cash provided by operating activities:	—	—	—
Depreciation and amortization	31	30	31
Loss on sale or disposal of property and equipment	−165,000	−234,000	−274,000
Deferred and other income taxes	23	14	23
Amortization of debt origination costs	2	2	5
Stock-based compensation costs	11	11	14
Non-cash operating lease cost	8	7	6
Write-off of supplier loan	10	0	0
Impairment loss	0	12	0
Other	0	−1	0
Changes in operating assets and liabilities, net of effects from acquisition:	—	—	—
Accounts receivable	4	16	6
Inventories	2	9	−24
Prepaid expenses and other current assets	7	−5	8
Accounts payable	−151,000	−19	−25
Accrued liabilities	3	7	−16
Operating lease liabilities	−8	−8	−7
Other	−32,000	898,000	1
Net cash provided by operating activities	258	252	249
Investing Activities	—	—	—
Purchases of property, plant and equipment	11	8	10
Acquisitions, net of cash acquired	124	8	11
Other	2	978,000	0
Net cash used in investing activities	−137	−17	−20
Financing Activities	—	—	—
Term Loan repayments	0	135	225
Borrowings under revolving credit agreement	40	0	0
Repayments under revolving credit agreement	40	0	0
Net increase in line of credit	3	0	0
Payment of debt costs	0	0	769,000
Payments of finance leases	2	5	3
Proceeds from exercise of stock options	4	15	18
Fair value of shares surrendered as payment of tax withholding	4	6	6
Repurchase of common stock	156	52	25
Other	−246,000	0	0
Net cash used in financing activities	−156	−182	−241
Effects of exchange rate changes on cash and cash equivalents	1	−573,000	180,000
(Decrease) increase in cash and cash equivalents	−34	51	−12
Cash and cash equivalents - end of year	—	—	—
Cash and cash equivalents - end of year	—	—	—
Interest paid	44	48	63
Income taxes paid	46	52	60

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro